Our aim was to investigate systemic nitric oxide (NO) production and its potential determinants such as insulin resistance. dyslipidemia, and circulating methylated analogs of Larginine in uncomplicated essential hypertension (EH). Nineteen newly diagnosed, unveated male subjects with mild pure unwmplicated EH and 11 normotensive controls were studied at rest after an overnight fast. The groups had comparable age. body mars index, creatinine clearance. cholesterol, fasting glucose, and insulin. In hypenensives, the urinary excretion rate of nitrite plus Nnate (Uno,), an index of endogenous NO production, was depressed (56 17 vs. 77 2 23 pollmmol matinine: p < 0.05). whereas plasma levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthesis, were increased (2.4 = 1.1 vs. I. I = 0.7 @ ; p < 0.005). Circulating wncenvations of symmetric dimethylarginine were similar in both groups (1.4 i 1.3 vs. 1.5 2 1.1 pM; p = NS). The L-argKine-toADMAratio was reduced in hypertension (3.3 f 0.5 vs. 4.5 f 0.P p < 0.001 for In-transformed data). There was no corelation b e tween Uno, and either the magnitude of insulin resistance or dyslipidemia in EH. Thus in male subjects with EH, endogenous systemic NO formation appears depressed, which is unrelated to accompanying insulin resistance or dyslipidemia Circulating ADMA levels are increased in uncomplicated EH, which may k of potential relevance. Key Words: Essential hypertensiohNitric oxide-Asymmetric dimethylarginine-Insulin resistanceDyslipidemia Endothelium-derived relaxing factorlnitric oxide (NO) is formed in endothelial cells from L-arginine by constitutive NO synthase (cNOS; 1.2) and continuously regulates vascular resistance in humans (3) via inmacellular generation of cyclic guanosine 3',5'-monophosphate (cGMP; 4). Under resting conditions, unheated essential hypertensive (EH) patients exhibit a lower dependence of vascular resistance on NO activity in the forearm (5, 6) and the heart (7). This may be due to depressed NO synthesis: however, some experiments with hypertensive animals suggested that the defect of the NO-dependent pathway may rather concern the ability of NO to produce biologic effects. Indeed, activity of endothelial NOS in spontaneously hypertensive rats was unchanged (8) or even increased (9), and potentiated rapid inactivation of NO by superoxide (10) was shown in these animals (8).
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Some data suggest that EH is also associated with increased oxidative stress (11); nevertheless. the lack of improvement of forearm endothelium-dependent vasodilation by superoxide dismutase argues rather in favor of depressed NO synthesis in EH (12) . Regardless of whether it is biologically active or inactivated, NO is ultimately converted to stable metabolites, nitrite plus nitrate (NOx) (13) . Because of the very short physiological half-life of NO (13 atinine; p c 0.01; Fig. 1 ).
EH subjects exhibited higher ADMA levels (EH vs. controls, 2.4 f 1.1 vs. 1.1 i 0.7 llM; p < 0.005; Fig. 2) and lower r-arginine-to-ADMA ratio (3.3 f 0.5 vs. 4.5 -c 0.8; p < 0.001 for In-transformed data; Fig. 2 ). Plasma SDMA levels were similar in both group (1.4 k 1.3 vs.
1.5 f 1.1 w, p = NS; Fig. 2 ). There were no correlations between creatinine clearance and plasma L-arginine, ADMA, or SDMAin either group (p = NS).
The effect of a history of EH on Uno,, U , , , plasma ADMA level, and In (L-arginine/ADMA) remained significant also in the two-way analysis of variance, with BMI over its median value (26.7 kg/mz) as the second between-groups factor in addition to EH. We observed neither significant effects of BMI exceeding the median on these variables nor interactions between BMI and the presence of EH (p = NS).
In EH patients analyzed as a separate group In (L-arginindADMA) inversely correlated with M (r = 4.56; p < 0.02) and IS1 (r = -0.46; p c 0.05); ADMA tended to correlate positively with the same variables ( r = 0.35; p = 0.13;andr=0.37,p=O.11 forMandIS1,respectively).
No significant correlation between Uno, or U , , , and 
DISCUSSION
We demonstrated that male subjects with uncompli. cated EH exhibit decreased urinary NOx excretion rare, an approximate index of endogenous NO synthesis In EH we also found increased plasma levels of ADMA, an endogenous -inhibitor of the NO synthesis, whereas SDMA, unable to inhibit cNOS at comparable levels (29,311, was unchanged.
Depression of urinary NOx in EH
The depression of Uno, and no differences in plasma NOx in newly diagnosed, untreated EH were reported Y Forte et al. (19) . who also observed reduced excretion of '5N-labeled nitrate after intravenous adminiitration of
These results are in contrast to those of Sagnella et al. (23) . who found similar nitrate excretion rates in urine samples collected after overnight fast in untreated patients with EH and normotensives.
However, Sagnella et al. stated only that both groups were matched for age, gender, and race, and none of the patien, had evidence of secondary hypertension, without an) comment on other exclusion cnteria or detailed characteristics of the subjects. In this study, we used selected male patients with newly diagnosed, untreated uncomplicated EH with no evidence of coexistent diseases and wellmatched normotensives of comparable age, BMI, and cholesterol. The exclusion of women enabled us to eliminate the effect of the menstrual cycle (39) on NO formation. We also removed other factors of potential influence on NO? levels such as smoking (40). clinically relevant atherosclerosis (20) . marked hypercholesterolemia (22). and inflammauon (2.18). The authors who found reduced Uno, (19) or decreased plasma NOx (21) studied selected EH subjects without coexistent diseases. Thus our results are compatible with the two previously mendoned reports.
A considerable proportion of both groups were overweight, which constitutes a drawback of this study. However, with regard to Uno, and U , , , we detected neither significant effects of BMI nor interactions between BMI and EH. Reports on the relation between BMI and the activity of the NO-dependent pathway are contradictory. In healthy subjects, Nestel et al. (41) found a negative correlation between BMI and forearm resistance vessels dilation to acetylcholine. Nevertheless, Tack et al. (42) EH subjects (5-7), which could have resulted from either depressed NO generation or augmented NO scavenging (10.13). In other words, normal or even increased Uno, would not allow conclusions on the preserved ability of NO to produce biologic effects. However, that in our study, Uno, was depressed in EH and correlated with the reduced U, , , , , argues in favor of lower NO release in EH, which can be due to lower endothelial cNOS activity.
We are not able to exclude an isolated defect in renal NO formation as a cause of lower Uno, in EH. However, some data suggested association of systemic and renal endothelial dysfunction in EH. In nondiabetic men with EH, BMI <30 kg/m2, normal serum creatinine, and urinary sediment (as in our study), plasma von Willebrand antigen level was increased only in those with microalbuminuria (44). Moreover, L-arginine produced both reduced increases in plasma cGMP and impaired renovascular dilation in uncomplicated EH (27).
Differences between EH subjects and controls of potential significance for Uno, EH subjects had lower insulin sensitivity and HDL cholesterol. a part of the IR-associated dyslipidemia (26). We observed no correlations between Uno, and IS1 or M within hypertensives, which is compatible with the lack of correlation between insulin sensitivity and local NOx generation in the foreann in insulin-resistant male subjects with non-insulin-dependent diabetes mellitus and insulin-sensitive controls (45). That study (45) suggested that the previously described association of IR and endothelial dysfunction in various states (25,46) does not signify that the degrees of these abnormalities are correlated. Although in EH, Higashi et al. (27) observed a correlation between the magnitude of IR and the degree of impairment of endothelial function, it is noteworthy that the latter was estimated on the basis of increases in plasma cCMP on L-arginine infusion, a stimulus that produced increases in plasma insulin (27). However. at normal insulin levels, as in our study, Utriainen et al. kg/m2, IR was unrelated to such measures of endothelial function as dilation of the brachial artery at high flow (49) 
ADMA levels in plasma in human hypertension
Goonasekera et al. (31) obsemed an increase of plasma ADMA and SDMA in childhood hypertension. However, the majority of their patients exhibited impairment of renal function, hypertension was the result of renal disease, and ADMA and SDMA levels inversely correlated with creatinine clearance, none of which was the case in our study. In renal failure, increase of SDMA is better related to abnormal renal function, as compared with ADMA (5456). Thus because we found increases of ADMA with unchanged SDMA and normal creatinine clearance, the underlying cause does not seem to be renal dysfunction.
Potential significance of increased ADMA levels in EH In this study, the finding of a correlation between pooled Uno, and In (L-arginine/ADMA) does not signify a causal relation between ADMA accumulation and depression of Uno, in EH because neither ADMA nor In (LarginindADMA) correlated with Uno, or U , , in any group when analyzed separately. That there was no correlation between ADMA and cholesterol contrasts with a previous report (20) and is probably due to the exclusion of the subjects with total cholesterol 26.4 mM.
Threshold ADMA levels necessary to affect vascular tone seem to be higher than those measured in hypenensive patients in our study. In isolated vessel rings, the statistically significant vasoconstrictive effects were observed at extracellular concentrations of ADMA added to or ADMNL-arginine ratio, respectively, whereas ADMA was increased to a similar degree as in our study. They also reported partial restoration of Uno, in hypercholestcrolemic animals (35) receiving oral L-arginine therapy. which increased the L-argininelADMA ratio only two-to threefold. Similar increases of circulating L-arginine TSduced monocyte adhesion into endothelial cells (58) a: .j inhibited platelet aggregation (66) in humans without affecting systemic hemodynamics in basal conditions. This suggests that relatively small changes in LWginineIADMA ratio may be of relevance. Accordingly. even if ADMA levels in our EH patients were too low to affect systemic vascular resistance by depressed cNOS activity (there was no relation between In (LarginiiidAiXA) and Uno,, UEGMP, or blood pressu:e i: the EH group), the significance of mildly increase" ADMA in EH cannot be excluded.
Higher ADMA levels can result from lower activity of dimerhylarginase, an enzyme metabolizing ADMA (63,671 or higher hydrolysis rate of proteins with methylated L-arginine residues (68) and increased synthesis of ADMA (62). That the L-arginine/ADMA ratio was higher and ADMA lower in insulin-resistant than in insulin-sensitive EH subjects suggests that ADMA accumulation i, independent of IR and requires further investigation.
In conclusion, our data suggest that in men with mild uncomplicated EH, endogenous NO formation is depressed, which may not be explained by associated insulin resistance or dyslipidemia. In addition, for the frst time. increased levels of ADMA in the plasma of adult EH subjects were found, which may be of pathophysiologic relevance. 
